{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:51:15Z","timestamp":1788580275970,"version":"build-2803163510"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2001,11,27]]},"DOI":"10.1212\/wnl.57.10.1774","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:54:14Z","timestamp":1336917254000},"page":"1774-1779","source":"Crossref","is-referenced-by-count":185,"title":["Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures"],"prefix":"10.1212","volume":"57","author":[{"given":"E.","family":"Faught","sequence":"first","affiliation":[{"name":"From the University of Alabama School of Medicine (Dr. Faught), Birmingham; Tallahassee Neurology Clinic (Dr. Ayala), FL; Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and the Minnesota Comprehensive Epilepsy Program (MINCEP) Epilepsy Care and the University of Minnesota (Dr. Leppik), Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ayala","sequence":"additional","affiliation":[{"name":"From the University of Alabama School of Medicine (Dr. Faught), Birmingham; Tallahassee Neurology Clinic (Dr. Ayala), FL; Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and the Minnesota Comprehensive Epilepsy Program (MINCEP) Epilepsy Care and the University of Minnesota (Dr. Leppik), Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. G.","family":"Montouris","sequence":"additional","affiliation":[{"name":"From the University of Alabama School of Medicine (Dr. Faught), Birmingham; Tallahassee Neurology Clinic (Dr. Ayala), FL; Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and the Minnesota Comprehensive Epilepsy Program (MINCEP) Epilepsy Care and the University of Minnesota (Dr. Leppik), Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. E.","family":"Leppik","sequence":"additional","affiliation":[{"name":"From the University of Alabama School of Medicine (Dr. Faught), Birmingham; Tallahassee Neurology Clinic (Dr. Ayala), FL; Comprehensive Epilepsy Care Center (Dr. Montouris), St. Louis, MO; and the Minnesota Comprehensive Epilepsy Program (MINCEP) Epilepsy Care and the University of Minnesota (Dr. Leppik), Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Zonisamide 922 Trial Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","first-page":"477","volume":"30","year":"1980","unstructured":"Masuda Y, Karasawa T, Shiraishi Y, Hori M, Yoshida K, Shimizu M. 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug: pharmacological profile. Arzneimittelforschung . 1980; 30: 477\u2013483.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00188a011"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(89)90041-7"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)90168-5"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(92)90087-A"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(96)80104-X"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1985.tb05407.x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(93)90021-X"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(93)90011-U"},{"key":"e_1_3_3_11_2","first-page":"275","volume":"144","year":"1988","unstructured":"Seino M, Ohkuma T, Miyasaka M. Efficacy evaluation of AD-810 (zonisamide): double-blind study comparing with carbamazepine. J Clin Exp Med . 1988; 144: 275\u2013291.","journal-title":"J Clin Exp Med"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540080059030"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(92)90010-C"},{"key":"e_1_3_3_14_2","first-page":"29","volume":"1","year":"1996","unstructured":"Perucca E, Bialer M. The clinical pharmacokinetics of the newer antiepileptic drugs: focus on topiramate, zonisamide and tiagabine. Clin Pharmacokinet . 1996; 1: 29\u201346.","journal-title":"Clin Pharmacokinet"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1987.tb03624.x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0287"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.57.10.1774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:23:45Z","timestamp":1711545825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.57.10.1774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,27]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,11,27]]}},"alternative-id":["10.1212\/WNL.57.10.1774"],"URL":"https:\/\/doi.org\/10.1212\/wnl.57.10.1774","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,27]]}}}